Policresulen

DB13492InvestigationalSmall molecule

Policresulen: Overview.

Resolves to

Compound
UNII6I19M5GB0GCAS101418-00-2
Clinical / RWD
RxNorm54908ATCD08AE02ATCG01AX03

What you can answer from here — as of March 06, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in
7Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
20Marketed productsAcross 6 countries and 9 labellers
Sign in
2ATC codesIncluding every combination product, plus 8 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Policresulen, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In